Posts by Dan Oatis

By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes, we can be too entrenched in our daily routine, entrenched in our field, and we can miss key factors that could change the way we think about what we do day to day. We recently conducted two parallel surveys that,…

Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t sound quite human and videos that could be deceptive altered deepfakes, consumers increasingly have questions about what is real. In a world of growing automation…

By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education for healthcare professionals. While these initiatives usually address “underrepresented communities,” in practice, they often refer to increasing participation among racial and ethnic groups. During Pride…

By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering patient advocacy group. At the Global Innovation in Patient Advocacy conference, one theme echoed throughout multiple presentations by patient advocates and industry representatives alike: it’s important to…

By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each of these estimated 5,000 to 7,000 or more rare diseases affects a relatively small number of individuals, the impact on those patients’ lives is significant.…

By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You have an investigative product that can impact lives globally, but do you have the right plan and partners in place to reach your patients and…

By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years of global pandemic. Yes, many events were in-person once again and lots of companies began pushing for people to return to the office, but have…

By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of flash-in-the-pan startups, building a company that doesn’t just last – but one that grows, thrives, and defines the industry it’s a part of – is…